Abstract
Background: Current malaria diagnostic tests do not reliably identify children at risk of severe and fatal infection. Host immune and endothelial activation contribute to malaria pathogenesis. Soluble urokinase-Type plasminogen activator receptor (suPAR) is a marker of these pathways. We hypothesized that measuring suPAR at presentation could risk-stratify children with malaria. Methods: Plasma suPAR levels were determined in consecutive febrile children with malaria at presentation to hospital in Jinja, Uganda.
| Original language | English (UK) |
|---|---|
| Pages (from-to) | E1079-E1086 |
| Journal | Clinical Infectious Diseases |
| Volume | 76 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Feb 2023 |
| Externally published | Yes |
Keywords
- mortality outcome
- prognostic marker
- risk-stratification
- severe malaria
- soluble urokinase-Type plasminogen activator receptor